期刊文献+

代谢综合征肾损害诊治进展 被引量:3

下载PDF
导出
摘要 代谢综合征(metabolic syndrome,MS)是以中心性肥胖(内脏性肥胖)、糖耐量减低、脂代谢异常、高胰岛素血症、高血压为主要特征,以胰岛素抵抗为共同病理生理基础,以合并出现多种代谢性疾病为临床特点的一组严重影响健康的临床症候群。与单纯糖尿病、高血压或脂代谢紊乱等导致的肾损害不同,目前越来越多研究结果表明,MS也能引起及加重肾损害,由此可见MS和肾脏疾病之间关系密切。本文拟就MS肾损害诊治进展作一综述。
出处 《中国医药导刊》 2008年第6期840-841,共2页 Chinese Journal of Medicinal Guide
  • 相关文献

参考文献16

  • 1Lira HS, Patel JV, Lip GY. Metabolic syndrome: a definition in progress. Circulation, 2004;110:35.
  • 2Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes meUitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998;15 : 539-553.
  • 3中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3046
  • 4El-Atat FA, Stas SN, McFarlane SI, et al. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol, 2004;15:2816-2827.
  • 5彭艾,刘志红,周虹,朱茂艳,黎磊石.胰淀素诱导人肾小球系膜细胞凋亡[J].肾脏病与透析肾移植杂志,2002,11(6):541-546. 被引量:6
  • 6Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med, 1974;81:440-447 .
  • 7董葆,陈文,程虹,李安,谌贻璞,邹万忠.肥胖相关性局灶节段性肾小球硬化症临床与病理表现[J].中华肾脏病杂志,2002,18(6):389-392. 被引量:32
  • 8Chagnac A, Weinstein T,Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol, 2003;14: 1480-1486.
  • 9Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int, 2001;59:498-1509.
  • 10Korbet SM. Primary focal segmental glomerutosclerosis. J Am Soc Nephrol, 1998, 9:1333-1340.

二级参考文献45

  • 1Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med,1974,81: 440-447.
  • 2Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant, 2001, 16:1790-1798.
  • 3Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int, 2001, 59:1498 - 1509.
  • 4Adelman R. Obesity and renal disease. Curr Opin Nephrol Hyperten, 2002, 11: 331-335.
  • 5Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbmninemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis,1991, 17: 330.
  • 6Praga M, Morales E, Herrero JC, et al. Absence of hypoalbuminemaia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltrafion. Am J Kidney Dis, 1999, 33: 52-58.
  • 7Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol, 2000,F817-F822.
  • 8Anderson PW, Zhang XY, Tiaa J, et al. Insulin and angiotensin Ⅱ are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int, 1996, 50: 745-753.
  • 9Fujiwara K, Hayashi K, Ozawa Y, et al. Renal protective effect of troglitazone in Wistar fatty rats. Metabolism, 2000, 49:1361-1364.
  • 10Wolf G, Hamann A, Han DC, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells. Kidney Int, 1999,56: 860-872.

共引文献3077

同被引文献24

  • 1赵海丹.代谢综合征与慢性肾脏疾病[J].人民军医,2008,51(12):778-779. 被引量:2
  • 2陈静,田志强,张伟国,陈金华,闫振成,倪银星,钟健,金婕,赵志钢,穆华,祝之明.腹内脂肪面积切点与代谢综合征临床检出率的关系[J].中华医学杂志,2006,86(30):2110-2113. 被引量:30
  • 3刘滨松,曹中朝.代谢综合征的肾损害[J].内蒙古医学杂志,2007,39(7):845-847. 被引量:4
  • 4Morishima M,Wang Y,Akiyoshi Y. Telmisartan,an angiotensin Ⅱ type 1 receptor antagonist,attenuates T-type Ca2 + channel expression in neonatal rat cardiomyocytes[J].European Journal of Pharmacology,2009,(1-3):105.doi:10.1016/j.ejphar.2009.03.024.
  • 5Zineh I,Luo X,Welder G J. Modulatory effects of atorvastatin on endothelial cell-dcrived chemokines,cytokines,and angiogenic factors[J].Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy,2006,(03):333.
  • 6Lee E J,Shin S H,Hyun S. Mutation of a putative S-nitrosylation site of TRPV4 protein facilitates the channel activates[J].Animal Cells Syst (Seoul),2011,(02):95.doi:10.1080/19768354.2011.555183.
  • 7Ali F,Hamdulay S S,Kinderlerer A R. Statin-mediated cytoprotection of human vascular endothelial cells:a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1[J].Journal of Thrombosis and Haemostasis,2007,(12):2537.
  • 8Naoto M,Kenji O,Yutaka O. Results of cardiac surgery in advanced liver cirrhosis[J].General Thoracic and Cardiovascular Surgery,2013,(02):79-83.
  • 9Shin M,Song SH,Kim JM. Effectiveness of Intraportal Prostaglandin E1 Administration After Liver Transplantation[J].Transplantation Proceedings,2012,(02):500-504.
  • 10Jia C,Dai C,Bu X. Co-administration of prostaglandin E1 with somatostatinattenuates acute liver damage after massive hepatectomy in rats via inhibition of inflammatory responses,apoptosis and endoplasmic reticulum stress[J].International Journal of Molecular Medicine,2013,(02):416-422.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部